Backbone vector plasmid of lentivirus construct driven by CAG promoter with puromycin resistance marker.
![]() Drawn by SnapGene® software |
|
Clone info. | Backbone vector plasmid of lentivirus construct driven by CAG promoter with puromycin resistance marker. |
---|---|
Comment | Made from CSII-EF-MCS(RDB04378) by replacing EF-1alpha promoter with CAG promoter derived from RDB07099. Commonly requested with pCMV-VSV-G-RSV-Rev (RDB04393) and pCAG-HIVgp (RDB04394). |
Vector backbone | CSII-EF-MCS (RDB04378) (plasmid) |
Selectable markers | Ampicillin (E. coli), Puromycin (mammalian cell) |
Growth conditions | LB+Amp, 30oC |
Growth remarks | Please note that Zeo resistance marker is not included in the lentivirus produced from this vector. E. coli: Amp^r. NEB Stable or an equivalent host is recommended for amplifying this clone. |
Depositor|Developer | Miyazono, Kohei | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Ordering instruction.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Ozawa, T. et al., iScience. 24(5): 102488, 2021) |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Ozawa, T. et al., iScience. 24(5): 102488, 2021)。 |
Catalog # | Resource name | Shipping form | Fee |
---|---|---|---|
RDB19592 | CSII-CA-MCS-IRES-Puro | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The CSII-CA-MCS-IRES-Puro was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB19592). |
Reference section:
Ozawa, T., Morikawa, M., Morishita, Y., Ogikubo, K., Itoh, F., Koinuma, D., Nygren, P.Å., Miyazono, K., Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice. iScience 24 (5): 102488 (2021). PMID 34113826. [PubMed] [Article] [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
original | Ozawa, T., Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice. iScience 24 (5): 102488 (2021). PMID 34113826. [PubMed] [Article] [RRC of NBRP] |
---|
Featured content